Cover Image
市場調查報告書

輔助人工心臟 (VAD)的全球市場 2017-2027年:各產品 (LAVD、RVAD、BiVAD)、用途 (BTT&BTD治療、DT、BTR治療)、地區的收益預測

Ventricular Assist Device (VAD) Market Forecast 2017-2027: Revenue Prospects by Product Type (LAVD, RVAD, BiVAD), Application (BTT & BTD Therapy, Destination Therapy, BTR Therapy) and Geography

出版商 Visiongain Ltd 商品編碼 509294
出版日期 內容資訊 英文 154 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
輔助人工心臟 (VAD)的全球市場 2017-2027年:各產品 (LAVD、RVAD、BiVAD)、用途 (BTT&BTD治療、DT、BTR治療)、地區的收益預測 Ventricular Assist Device (VAD) Market Forecast 2017-2027: Revenue Prospects by Product Type (LAVD, RVAD, BiVAD), Application (BTT & BTD Therapy, Destination Therapy, BTR Therapy) and Geography
出版日期: 2017年04月25日 內容資訊: 英文 154 Pages
簡介

2017年的全球輔助人工心臟 (VAD)的收益規模估計超越9億美元。由於心臟疾病的盛行率擴大,老年人口的增加等影響,預計也將持續強力成長到2027年。

本報告提供全球輔助人工心臟 (VAD)的市場調查,產品概要,作用與機能,各種類型主要的產品,開發中產品分析,市場成長的各種影響因素及市場機會分析,各產品類型、用途、地區/主要國家趨勢與市場規模的變化與預測,主要企業簡介,未來展望等彙整資料。

第1章 報告概要

第2章 簡介:輔助人工心臟 (VAD) 市場

  • VAD所扮演的角色、功能
  • 輔助人工心臟 (VAD) 是什麼?
  • VAD的各種類型
  • VAD的發展的過程
  • 主要VAD產品

第3章 市場概要、定性分析

  • 波特的五力分析
  • 開發平台分析
    • ReliantHeart HeartAssist 5 VAD System
    • HeartMate III LVAS
    • HeartMate PHP
  • 專利分析
  • 市場動態
  • 市場課題
  • 市場機會
  • 市場趨勢

第4章 市場預測:各類型

  • 左心輔助人工心臟 (LVAD)
    • 趨勢
    • 成長因素
  • 右心輔助人工心臟 (RVAD)
    • 趨勢
    • 成長因素
  • 兩心輔助人工心臟 (BiVAD)
    • 趨勢
    • 成長因素

第5章 市場預測:各用途

  • BTT&BTD治療
  • DT
  • BTR治療

第6章 市場預測:各地區

  • 北美
    • 美國
    • 墨西哥
    • 加拿大
  • 歐洲
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 亞太地區
    • 印度
    • 中國
    • 日本
    • 其他
  • 其他地區
    • 南美
    • 中東
    • 非洲

第7章 主要企業

  • Abiomed, Inc.
  • Berlin Heart GmbH
  • HeartWare International, Inc.
  • Jarvik Heart, Inc.
  • LivaNova PLC
  • ReliantHeart, Inc.
  • 其他

第8章 總論

  • 目前主要市場區隔
  • 主要企業
  • 主要地區市場
  • 新興市場
  • 市場未來性

第9章 用語

目錄
Product Code: PHA0185

Ventricular Assist Devices - our new study reveals trends, R&D progress, and predicted revenues

Where is the VAD market heading? If you are involved in this sector you must read this brand new report. Visiongain's report shows you the potential revenues streams to 2027, assessing data, trends, opportunities and business prospects there.

Discover How to Stay Ahead

Our 154-page report provides 104 tables, charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing VAD market. See how to exploit the opportunities.

Forecasts to 2027 and other analyses reveal the commercial prospects

  • In addition to revenue forecasting to 2027, our new study provides you with recent results, growth rates, and market shares.
  • You find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.

Discover sales predictions for the world market and submarkets

Along with revenue prediction for the overall world market, there are forecasts for 3 Product Types and 3 Applications.

Ventricular Assist Devices Market Forecasts to 2027, By Product Type

  • RVAD
  • LVAD
  • BiVAD

Ventricular Assist Devices Market Forecasts to 2027, By Product

  • BTT Therapy & BTD Therapy
  • Destination Therapy
  • BTR Therapy

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 6 regional and 12 leading national markets:

  • North America:
    • The US
    • Mexico
    • Canada
  • Europe:
    • Germany
    • France
    • The UK
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific:
    • Japan
    • China
    • India
    • Rest of Asia Pacific
  • Rest of World:
    • Latin America
    • Middle East
    • Africa

The report also includes profiles and forecasts for some of the leading companies in the Ventricular Assist Device market, with a focus on the VAD segment of these companies' operations.

There will be growth in both established and in developing countries. Our analyses show that the developing markets, China and India in particular, will continue to achieve high revenue growth to 2027. Developments worldwide in medical device regulation, especially in the US and Japan will influence the market.

Leading companies and the potential for market growth

Overall world revenue for VAD will surpass $900m in 2017, our work calculates. We predict strong revenue growth through to 2027. The increasing prevalence of heart disease, and increasing ageing population will increase sales to 2027.

Our work identifies which organisations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How the VAD Market report helps you

In summary, our 154-page report provides you with the following knowledge:

  • Revenue forecasts to 2027 for the world Ventricular Assist Devices market and 2 different segmentations, with 3 product categories and 3 applications - discover the industry's prospects, finding the most lucrative places for investments and revenues
  • Revenue forecasts to 2027 for 6 regional markets and 12 of the leading national markets - US, Mexico, Canada, Germany, UK, France, Italy, Spain, Japan, China, India, Russia,
  • Discussion of what stimulates and restrains companies and the market
  • Prospects for established firms and those seeking to enter the market

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.

Information found nowhere else

With our survey you are less likely to fall behind in knowledge or miss opportunity. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.

Visiongain's study is for everybody needing commercial analyses for the Ventricular Assist device market and leading companies. You find data, trends and predictions.

Get our report today Ventricular Assist Device (VAD) Market Forecast 2017-2027: Revenue Prospects by Product Type (LAVD, RVAD, BiVAD), Application (BTT & BTD Therapy, Destination Therapy, BTR Therapy) and Geography. Avoid missing out - get our report now.

visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Report Overview

  • 1.1. Global Ventricular Assist Device (VAD) Market Definition
  • 1.2. Methodology
    • 1.2.1. Primary Research
    • 1.2.2. Secondary Research
    • 1.2.3. Market Evaluation & Forecasting Methodology
  • 1.3. Ventricular Assist Device (VAD) Report Structure
  • 1.4. Why You Should Read This Report
  • 1.5. How this Report Delivers
  • 1.6. Key Questions Answered by This Analytical Report Include:
  • 1.7. Who is This Report For?
  • 1.8. Frequently Asked Questions (FAQ)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Introduction to the Ventricular Assist Device (VAD) Market

  • 2.1. The Role and Function of VADs
  • 2.2. What is a Ventricular Assist Device (VAD)?
  • 2.3. Type of VADs?
  • 2.4. Brief History of VADs
  • 2.5. Key VAD products

3. Market Overview Global Ventricular Assist Device (VAD) Market, Qualitative Analysis

  • 3.1. Porter's Five Forces Analysis
  • 3.2. Porter's Five Forces Analysis of Ventricular Assist Device (VAD) Market
    • 3.2.1. Rivalry among Competitors [High]
    • 3.2.2. Threat of New Entrants [Medium]
    • 3.2.3. Power of Suppliers [Low]
    • 3.2.4. Power of Buyers [Medium]
    • 3.2.5. Threat of Substitutes [Medium]
  • 3.3. Pipeline Analysis
    • 3.3.1. Key Information about Pipeline Products
    • 3.3.2. ReliantHeart HeartAssist 5 VAD System
    • 3.3.3. HeartMate III LVAS
    • 3.3.4. HeartMate PHP
  • 3.4. Patent Analysis
  • 3.5. Global Ventricular Assist Devices (VAD) Market Dynamics
    • 3.5.1. Unavailability of Heart Donors
    • 3.5.2. Technological Advancements
    • 3.5.3. Rising incident of Heart Failure
    • 3.5.4. Favourable Reimbursement Policies
  • 3.6. Global Ventricular Assist Devices (VAD) Market Challenges
    • 3.6.1. Existence of Alternative Treatments
    • 3.6.2. Complications Associated with VAD Implantation
    • 3.6.3. Rise in Number of Product Recalls
    • 3.6.4. Low Adoption Rate in Emerging Countries
  • 3.7. Global Ventricular Assist Devices (VAD) Market Opportunities
    • 3.7.1. Lucrative opportunities in emerging economies
  • 3.8. Global Ventricular Assist Devices (VAD) Market Trends
    • 3.8.1. Increased adoption of VADs for BTT Therapy
    • 3.8.2. Growing Merger & Acquisitions
    • 3.8.3. Increase in Clinical Trials
    • 3.8.4. Rising Number of Cardiac Centres in the USA

4. Global Ventricular Assist Device (VAD) Market by Type Forecast 2017-2027

  • 4.1. Left Ventricular Assist Device (LVAD)
    • 4.1.1. Global Left Ventricular Assist Device (LVAD) Trends
    • 4.1.2. Global Left Ventricular Assist Device (LVAD) Growth Factors
  • 4.2. Right Ventricular Assist Device (RVAD)
    • 4.2.1. Global Right Ventricular Assist Device (RVAD) Trends
    • 4.2.2. Global Right Ventricular Assist Device (RVAD) Growth Factors
  • 4.3. Bi-Ventricular Assist Device (BiVAD)
    • 4.3.1. Global Bi-Ventricular Assist Device (BiVAD) Trends
    • 4.3.2. Global Bi-Ventricular Assist Device (BIVAD) Growth Factors

5. Global VAD Market, By Application, Forecast 2017-2027

  • 5.1. BTT Therapy & BTD Therapy
  • 5.2. Destination Therapy
  • 5.3. BTR Therapy

6. Leading Regional Global Ventricular Assist Device (VAD) Market Forecast 2017-2027

  • 6.1. North America Ventricular Assist Device (VAD) Market Analysis
    • 6.1.1. USA VAD Market Analysis
      • 6.1.1.1. USA Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.1.2. Mexico VAD Market Analysis
      • 6.1.2.1. Mexico Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.1.3. Canada VAD Market Analysis
      • 6.1.3.1. Canada Ventricular Assist Devices Market Forecasts 2017-2027
  • 6.2. Europe Ventricular Assist Device (VAD) Market Analysis
    • 6.2.1. Europe Ventricular Assist Device (VAD) Market Forecast
    • 6.2.2. U.K. Ventricular Assist Device (VAD) Market Analysis
      • 6.2.2.1. U.K. Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.2.3. France Ventricular Assist Device (VAD) Market Analysis
      • 6.2.3.1. France Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.2.4. Germany Ventricular Assist Device (VAD) Market Analysis
      • 6.2.4.1. Germany Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.2.5. Italy Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.2.6. Spain Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.2.7. Russia Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.2.8. Rest of Europe Ventricular Assist Devices Market Forecasts 2017-2027
  • 6.3. Asia-Pacific Ventricular Assist Device (VAD) Market Analysis
    • 6.3.1. Asia-Pacific Ventricular Assist Device (VAD) Market Forecast
    • 6.3.2. India Ventricular Assist Device (VAD) Market Analysis
      • 6.3.2.1. India Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.3.3. China Ventricular Assist Device (VAD) Market Analysis
      • 6.3.3.1. China Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.3.4. Japan Ventricular Assist Device (VAD) Market Analysis
      • 6.3.4.1. Japan Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.3.5. Other Asia-Pacific Ventricular Assist Device (VAD) Market Analysis
      • 6.3.5.1. Other Asia-Pacific Ventricular Assist Devices Market Forecasts 2017-2027
  • 6.4. Rest of the World Ventricular Assist Device (VAD) Market Analysis
    • 6.4.1. Rest of the World Ventricular Assist Device (VAD) Market Forecast
    • 6.4.2. Latin America Ventricular Assist Device (VAD) Market Analysis
      • 6.4.2.1. Latin America Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.4.3. Middle East Ventricular Assist Device (VAD) Market Analysis
      • 6.4.3.1. Middle East Ventricular Assist Devices Market Forecasts 2017-2027
    • 6.4.4. Africa Ventricular Assist Device (VAD) Market Analysis
      • 6.4.4.1. Africa Ventricular Assist Devices Market Forecasts 2017-2027

7. Leading Companies in Global Ventricular Assist Device (VAD) Market

  • 7.1. Abiomed, Inc.
    • 7.1.1. Company Introduction
    • 7.1.2. Abiomed Business Segments:
    • 7.1.3. Abiomed Business Performance:
    • 7.1.4. Abiomed Revenue, 2013-2015
    • 7.1.5. Abiomed Research and Developments:
    • 7.1.6. SWOT Analysis of Abiomed Inc.
  • 7.2. Berlin Heart GmbH
    • 7.2.1. Company Introduction
    • 7.2.2. Berlin Heart GmbH Business Segments:
    • 7.2.3. Berlin Heart GmbH Research and Developments:
    • 7.2.4. SWOT Analysis of Berlin Heart GmbH
  • 7.3. HeartWare International, Inc.
    • 7.3.1. Company Introduction
    • 7.3.2. HeartWare Business Segments:
    • 7.3.3. HeartWare Business Performance:
    • 7.3.4. HeartWare Revenue, 2013-2015
    • 7.3.5. Key Strategic Moves & Developments
    • 7.3.6. SWOT Analysis of HeartWare
  • 7.4. Jarvik Heart, Inc.
    • 7.4.1. Company Introduction
    • 7.4.2. Jarvik heart: Business Segments
    • 7.4.3. Key Strategic Moves & Developments
    • 7.4.4. Jarvik heart: SWOT Analysis
  • 7.5. LivaNova PLC
    • 7.5.1. Company Introduction
    • 7.5.2. LivaNova Business Segments
    • 7.5.3. LivaNova: Business Performance
    • 7.5.4. LivaNova: net sales, 2013-2015 ($Million)
    • 7.5.5. LivaNova: SWOT Analysis
  • 7.6. ReliantHeart, Inc.
    • 7.6.1. ReliantHeart: Company Overview
    • 7.6.2. ReliantHeart: Operating Business Segments
    • 7.6.3. ReliantHeart: Key Strategic Developments
    • 7.6.4. ReliantHeart: SWOT Analysis
  • 7.7. Other Companies of Interest in the VAD Market

8. Conclusions

  • 8.1. Current Leading Ventricular Assist Device Segments
  • 8.2. Leading Ventricular Assist Devices Companies
  • 8.3. Leading Regional Markets
  • 8.4. Emerging Ventricular Assist Devices Markets
  • 8.5. The Future of the Ventricular Assist Devices Market?

9. Glossary

  • 9.1. VAD Patent Registrations 2010-2017
  • Visiongain Report Sales Order Form
  • Appendix A
  • About Visiongain
  • Appendix B
  • Visiongain report evaluation form

List of Figures

  • Figure 1.1: Global Ventricular Assist Device Market Segmentation Overview, 2017
  • Figure 2.1: Global VAD Market Product Overview, 2017
  • Figure 3.1: Market segmentation for Ventricular Assist Device (VAD)
  • Figure 3.2: Porter's Five Forces Analysis of Ventricular Assist Device (VAD) Market, 2017-2027
  • Figure 3.3: Patent Analysis of Ventricular Assist Device (VAD) Market, by region, 2010-2017
  • Figure 3.4: Patent Analysis of Ventricular Assist Device (VAD) Market, by Year, 2010-2017
  • Figure 3.5: Patent Analysis of Ventricular Assist Device (VAD) Market, by region, 2010-2017
  • Figure 3.6: Impact of Drivers
  • Figure 3.7: Impact of Challenges
  • Figure 3.8: Impact of Trends
  • Figure 4.1: Global Ventricular Assist Device (VAD) Market Forecasts, by Product, Market Share (%), 2016
  • Figure 4.2: Ventricular Assist Devices Market, by Product, Forecast ($million) 2016-2027
  • Figure 4.3: Global Ventricular Assist Device (VAD) Market Forecasts By Type ($m, AGR%) 2017-2027
  • Figure 4.4: Global Left Ventricular Assist Device (LVAD) Market Forecasts ($m, AGR%) 2017-2027
  • Figure 4.5: Global Right Ventricular Assist Device (RVAD) Market Forecasts ($m, AGR%) 2017-2027
  • Figure 4.6: Global Bi-Ventricular Assist Device (BIVAD) Market Forecasts ($m, AGR%) 2017-2027
  • Figure 5.1: Global Ventricular Assist Device (VAD) Market
  • Figure 5.2: Global Ventricular Assist Device Market Forecast, by Application, Market Share (%), 2016
  • Figure 5.3: Global Ventricular Assist Device Market Forecast, by Application, ($million) 2016-2027
  • Figure 5.4: Global Ventricular Assist Device (VAD) Market Forecasts By Application ($m, AGR%) 2017-2027
  • Figure 5.5: Global BTT Therapy & BTD Therapy Market Forecasts ($m, AGR%) 2017-2027
  • Figure 5.6: Global Destination Therapy Market Forecasts ($m, AGR%) 2017-2027
  • Figure 5.7: Global BTR Therapy Market Forecasts ($m, AGR% CAGR%) 2017-2027
  • Figure 6.1: Global Ventricular Assist Device Market Forecast, by Geography, Market Share (%), 2016
  • Figure 6.2: Global Ventricular Assist Device Market Forecast, by Geography,($million) 2016-2027
  • Figure 6.3: North America Ventricular Assist Devices Market, by Country, Market Share (%), 2016
  • Figure 6.4: North America Ventricular Assist Devices Market, by Country, ($million) 2016-2027
  • Figure 6.5: USA Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%)2017-2027
  • Figure 6.6: Mexico Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.7: Canada Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.8: Europe Ventricular Assist Devices Market, by Country, Market Share (%), 2016
  • Figure 6.9: Europe Ventricular Assist Devices Market, by Country, ($million) 2016-2027
  • Figure 6.10: U.K. Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.11: France Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.12: Germany Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.13: Italy Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.14: Spain Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.15: Russia Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.16: Rest of Europe Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.17: Asia-Pacific Ventricular Assist Devices Market, by Country, Market Share (%), 2016
  • Figure 6.18: Asia-Pacific Ventricular Assist Devices Market, by Country, ($million) 2016-2027
  • Figure 6.19: India Ventricular Assist Devices Market Forecast($m, AGR% CAGR%) 2017-2027
  • Figure 6.20: China Ventricular Assist Devices Market Forecast($m, AGR% CAGR%) 2017-2027
  • Figure 6.21: Japan Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.22: Other Asia-Pacific Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.23: Rest of the World Ventricular Assist Devices Market, by Country, Market Share (%), 2016
  • Figure 6.24: Rest of the World Ventricular Assist Devices Market, by Country, ($million) 2016-2027
  • Figure 6.25: Latin America Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.26: Middle East Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 6.27: Africa Ventricular Assist Devices Market Forecast ($m, AGR% CAGR%) 2017-2027
  • Figure 7.1: Abiomed sales analysis, by business segments, 2013-2015, $m
  • Figure 7.2: SWOT Analysis of Abiomed Inc.
  • Figure 7.3: Berlin Heart SWOT analysis
  • Figure 7.4: HeartWare sales analysis, by business segments, 2013-2015, $Mn
  • Figure 7.5: HeartWare: Revenue by geography, 2015(%)
  • Figure 7.6: HeartWare SWOT analysis
  • Figure 7.7: Jarvik heart SWOT analysis
  • Figure 7.8: LivaNova sales analysis, by business segments, 2013-2015, $Mn
  • Figure 7.9: LivaNova: revenue by business segments, 2015(%)
  • Figure 7.10: LivaNova: Revenue by geography, 2015(%)
  • Figure 7.11: LivaNova SWOT analysis
  • Figure 7.12: ReliantHeart SWOT analysis

List of Tables

  • Table 3.1: Snapshot of Pipeline for VADs
  • Table 3.2: VAD Pipeline: ReliantHeart Assist Device
  • Table 3.3: VAD Pipeline: HeartMate III LVAS
  • Table 3.4: VAD Pipeline: HeartMate PHP
  • Table 4.1: Global Ventricular Assist Device (VAD) Market Forecasts By Type ($mn, AGR% CAGR%) 2022-2027
  • Table 4.2: Global Left Ventricular Assist Device (LVAD) Market Forecasts ($m, AGR%) 2016-2027
  • Table 4.3: Global Right Ventricular Assist Device (RVAD) Market Forecasts ($m, AGR%) 2016-2027
  • Table 4.4: Global Bi-Ventricular Assist Device (BIVAD) Market Forecasts ($m, AGR%) 2016-2027
  • Table 5.1: Global Ventricular Assist Device (VAD) Market Forecasts By Application ($m, AGR%) 2022-2027
  • Table 5.2: Global BTT Therapy & BTD Therapy Market Forecasts ($m, AGR%) 2016-2027
  • Table 5.3: Global Destination Therapy Market Forecasts ($m, AGR%) 2016-2027
  • Table 5.4: Global BTR Therapy Market Forecasts ($m, AGR%) 2016-2027
  • Table 6.1: Global Ventricular Assist Device Market Forecast, by Geography ($m, AGR% CAGR%) 2016-2027
  • Table 6.2: North America Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027
  • Table 6.3: USA Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.4: Mexico Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.5: Canada Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.6: Europe Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027
  • Table 6.7: U.K. Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.8: France Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.9: Germany Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.10: Italy Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.11: Spain Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.12: Russia Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.13: Rest of Europe Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.14: Asia-Pacific Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027
  • Table 6.15: India Ventricular Assist Devices Market Forecasts ($m, AGR%, CAGR%) 2016-2027
  • Table 6.16: China Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.17: Japan Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.18: Other Asia-Pacific Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.19: Rest of the World Ventricular Assist Devices Market Forecasts By Country ($m, AGR% CAGR%) 2016-2027
  • Table 6.20: Latin America Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.21: Middle East Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 6.22: Africa Ventricular Assist Devices Market Forecasts ($m, AGR% CAGR%) 2016-2027
  • Table 7.2: Abiomed Inc.: Recent Developments
  • Table 7.4: Berlin Heart Gmbh: Recent Developments
  • Table 7.6: HeartWare International Inc.: Recent Developments
  • Table 7.7: Jarvik Heart Inc.: Company Snapshot
  • Table 7.8: Jarvik Heart Inc.: Recent Developments
  • Table 7.9: LivaNova Plc: Company Snapshot
  • Table 7.10: LivaNova: operating segments
  • Table 7.12: ReliantHeart: Recent Developments
  • Table 7.1: Other Companies of Interest
  • Table 7.13: Other Companies of Interest (continued)
  • Table 8.1: Global Ventricular Assist Device (VAD) Market Overview, 2017-2027
  • Table 9.1: Patents Registered for Ventricular Assist Devices 2017
  • Table 9.2: Patents Registered for Ventricular Assist Devices 2016
  • Table 9.3: Patents Registered for Ventricular Assist Devices 2015
  • Table 9.4: Patents Registered for Ventricular Assist Devices 2014
  • Table 9.5: Patents Registered for Ventricular Assist Devices 2013
  • Table 9.6: Patents Registered for Ventricular Assist Devices 2012
  • Table 9.7: Patents Registered for Ventricular Assist Devices 2011
  • Table 9.8: Patents Registered for Ventricular Assist Devices 2010

Companies Listed

  • Abbottdiabetescare.Com
  • ABIOMED, Inc.
  • Acelity LP, Inc.
  • Advocate Health Care Network
  • Alere, Inc.
  • ALung Technologies Inc.
  • American Heart Association
  • Animas Corporation
  • Asahi Kasei Medical Co. Ltd.
  • Baxter International, Inc.
  • Bodytel Gmbh
  • Boston Scientific Corp.
  • C.R. Bard, Inc. (New Jersey)
  • Cedars-Sinai
  • Cellnovo Group SA
  • Circulite Inc.
  • CryoLife, Inc.
  • DexCom, Inc.
  • Edwards Lifesciences Corp.
  • Exactech, Inc.
  • Guidant Corporation
  • HeartWare International, Inc.
  • Insulet Corp.
  • International Society For Heart And Lung Transplantation Inc
  • Jarvik Heart Inc.
  • LeMaitre Vascular, Inc.
  • Leviticus-Cardio Ltd.
  • LivaNova Plc
  • Mayo Foundation For Medical Education And Research
  • Medtronic Plc
  • Micromed Cardiovascular Inc.
  • Nipro Corp.
  • NuVasive, Inc.
  • On-X Life Technologies Inc.
  • Option Care Enterprises Inc.
  • Organ Recovery Systems Inc.
  • Peter Brasseler Holdings Llc
  • Presence Prv Health
  • Smith & Nephew Plc
  • St. Jude Medical, Inc.
  • Sunshine Heart, Inc.
  • Teleflex, Inc.
  • Terumo Corp.
  • Terumo Heart Incorporated
  • Thoratec Corporation
  • United Network For Organ Sharing
  • Valtech Cardio Ltd
  • Visualase Inc.
  • Walgreens Infusion Services Inc.
  • World Heart Corporation
  • Zimmer Biomet Holdings, Inc.

List of Organizations

  • Advocate Health Care Network
  • American Heart Association
  • Food and Drug Administration (FDA)
  • Health Canada
  • Mayo Foundation For Medical Education And Research
  • Ministry of Health, Labor, and Welfare (MHLW)
  • National Health Service (UK)
  • National Institutes of Health (NIH)
  • Presence Prv Health
  • United Nations
  • United Network For Organ Sharing
  • World Health Organization (WHO)
Back to Top